Physician profile
Simran Sekhon
NPI 1225262264
$831.74
in general payments reported to CMS, 2019-2025
17 companies · $79.96 in 2025
The $79.96 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $199 · 2023: $249 · 2024: $192 · 2025: $79.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.97 |
| Education | $108.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $188.71 | 2022-2025 | Enhertu, Imfinzi |
| Lilly USA, LLC | $134.94 | 2023 | Verzenio, Jaypirca |
| Alexion Pharmaceuticals, INC. | $125.00 | 2024 | |
| Amgen INC. | $82.34 | 2021-2022 | |
| Incyte Corporation | $48.79 | 2023 | Monjuvi, Jakafi |
| Merck Sharp & Dohme LLC | $45.07 | 2022-2025 | Welireg, Keytruda |
| Stemline Therapeutics INC. | $25.49 | 2021 | |
| Genmab U.S., INC. | $23.08 | 2023 | Epkinly |
| Pacira Pharmaceuticals Incorporated | $22.58 | 2023 | Exparel |
| Mylan Institutional INC. | $20.21 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $19.87 | 2021 | |
| Pharmaessentia USA Corporation | $19.20 | 2023 | Besremi |
| Solventum Corporation | $16.60 | 2024 | V.A.C.Instill, Activ.A.C. |
| Exelixis INC. | $16.27 | 2022 | |
| Janssen Biotech, INC. | $14.81 | 2024 | Talvey, Tecvayli |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $14.39 | 2025 | |
| Pharmacosmos Therapeutics INC. | $14.39 | 2024 | Cosela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simran Sekhon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.